Hospitals provide comprehensive patient monitoring and support, making them key distribution points for Tamiflu since centralized systems allow them to purchase and distribute in large quantities, negotiate price variations more effectively, and stabilize the supply of goods. The surge in demand for Tamifl...
Ltd. obtained the general distribution rights in Mainland China for the anti-influenza drug from Natco Pharma Limited ("Natco"). The first batch of cargo has arrived at the port in Chongqing City, and the drug will be introduced to the market for domestic treatment and prevention of Type A...
In March 2022, Natco Pharma announced the launch of the first generic version of Celgene's top-selling cancer medicine Revlimid (lenalidomide capsules) in the United States market with its marketing partner Arrow International, an affiliate of Israeli pharma maker Teva Pharmaceutical Industries. ...